Skip to content

ELI

Active
Private limited companyfounded 2021active for 5 yearsHofweg 12, 3600 Genk, BelgiumKBO/BCE: BE 0763.330.315
Summary

ELI has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €61,422 and a net result of €5,311. Equity is growing by about 15% per year across the filed financial years. Its solvency ranks better than 95% of 26,023 sector peers (NACE 47, financial year 2024). The computed 12-month bankruptcy probability is 0.6% (low).

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€66,869total assets 2024
Equity
€61,422
Profit
€5,311
Turnover not published (abbreviated or micro format)
Financial health
72 Healthy Checked score 2024
Bankruptcy probabilitywithin 12 months
0.6%
Structure
Accounts 71 days overdue0 of 1 deed read
Why 72raises riskFigures for financial year 2024 (filed 28-05-2025)Founded in 2021lowers riskLiquidity: current ratio 12.26, cash €42,824Equity €61,422 (91.9% of total assets)Show the evidence

Checked score

Score 2024
72 / 100
Healthy
Probability in this band: 0.55% to 1.5%
Financially better than 80% of its sector peers (NACE 47, micro)
Financial strength · tick = 2023
Strong
Solvency 100=
equity 91.9% of total assets
Liquidity 100=
short-term debt 8.1% · cash 64.0%
Profitability 79-3
return on assets 7.9%
Bankruptcy probability, 12 months
0.6% Low
0%0.5%1.5%4%10%≥ 25%

About 6 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,187 companies, NACE 47, micro)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026lowest value 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.3%▲ +0.2 percentage points vs 07-2026 09-2026: 0.3%● unchanged vs 08-2026 10-2026: 0.6%▲ +0.3 percentage points vs 09-2026highest value
Credit of up to €4,000 on 30-day terms is acceptable
Liquidity ample (current ratio 12.26, compared with 32.22 in 2023; short-term debt: 8.1% and cash: 64% of total assets), and 8.1% of the assets are financed with debt.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 92% on solvency, 99% on liquidity, 69% on profitability and 60% on growth.

The bankruptcy probability was computed on 10-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
raises risk · Figures for financial year 2024 (filed 28-05-2025)
NBB · annual accounts
lowers risk · Liquidity: current ratio 12.26, cash €42,824
NBB · annual accounts
lowers risk · Equity €61,422 (91.9% of total assets)
NBB · annual accounts
raises risk · Founded in 2021
How long the company has existed counts in the probability; how much depends on the rest of its profile.
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 28-05-2025, 64 days ahead of the deadline.
NBB · 4 filings
Deviation from the deadline
2025
not confirmed
2024
64 days early
2023
57 days early
2022
62 days early
2021
25 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 4 accounts on average 52 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2024 · micro…
  2. Annual accounts filedfinancial year 2023 · micro…
  3. Liquidity more than quadruplescurrent ratio 32.22

Key points

  • Positive: Among the best 5% on solvencysector median 32.2% · 26,023 companies 91.9% View
  • Caution: Accounts not fileddeadline was 31-07-2026 71 days late View
  • Total assets 20244 financial years filed €66,869 View

By topic

Financials

Financial year
2024
Total assets
€66,869
Profit
€5,311
Solvency
91.9%
Total assets▲ 15.5%
Net result
20212024
Go to Financials

Timeline

Events
5
Since
2022
  1. 30-05-2023Annual accounts filed
  2. 06-07-2022Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
08-02-2021
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.